Harrison.ai vs Magentiq Eye

Harrison.ai, formerly Annalise.ai, sells chest X-ray, head CT and chest CT reading to radiology departments and teleradiology services. Its vendor figures run to 124 findings on chest X-ray and 130 on head CT, and openFDA lists its decisions as chest X-ray and CT brain triage products plus Annalise Enterprise. It raised a US$112M Series C in February 2025. Magentiq Eye sells into endoscopy. A GI practice or hospital endoscopy unit connects MAGENTIQ-COLO to the video output of its Olympus, Fujinon, Pentax or Sonoscape tower and rents it monthly, and Magentiq says it highlights polyps in real time. A randomized tandem trial in Lancet Digital Health, funded by Magentiq, enrolled 916 patients and found 0.70 adenomas per colonoscopy with the AI against 0.51 with conventional colonoscopy, though the abstract does not name the product. Harrison.ai's use cases name hospitals and teleradiology while Magentiq's page describes endoscopy towers.